blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1254133

EP1254133 - INDOL-3-YL DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITORS [Right-click to bookmark this link]
Former [2002/45]INDOL-3-YL DERIVATIVES
[2004/46]
StatusNo opposition filed within time limit
Status updated on  24.02.2006
Database last updated on 23.04.2024
Most recent event   Tooltip05.12.2008Lapse of the patent in a contracting state
New state(s): CY		published on 07.01.2009  [2009/02]
Applicant(s)For all designated states
Merck Patent GmbH
Frankfurter Strasse 250
64293 Darmstadt / DE
[N/P]
Former [2002/45]For all designated states
MERCK PATENT GmbH
Frankfurter Strasse 250
64293 Darmstadt / DE
Inventor(s)01 / GOODMAN, Simon
Friedrich-Ebert Strasse 102a
64347 Griesheim / DE
02 / GOTTSCHLICH, Rudolf
Buchenweg 1
64354 Reinheim / DE
03 / WIESNER, Matthias
Buchenweg 73
55128 Mainz / DE
 [2002/45]
Application number, filing date01903624.305.01.2001
[2002/45]
WO2001EP00084
Priority number, dateDE200010613911.02.2000         Original published format: DE 10006139
[2002/45]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report
No.:WO0158893
Date:16.08.2001
Language:DE
[2001/33]
Type: A2 Application without search report 
No.:EP1254133
Date:06.11.2002
Language:DE
The application published by WIPO in one of the EPO official languages on 16.08.2001 takes the place of the publication of the European patent application.
[2002/45]
Type: B1 Patent specification 
No.:EP1254133
Date:20.04.2005
Language:DE
[2005/16]
Type: B9 Corrected patent specification 
No.:EP1254133
Date:07.09.2005
[2005/36]
Search report(s)International search report - published on:EP18.04.2002
ClassificationIPC:C07D401/12, A61K31/404, A61P43/00, C07D403/12, C07D417/14, C07D209/18
[2002/45]
CPC:
C07D401/12 (EP,KR,US); A61P19/02 (EP); A61P19/10 (EP);
A61P25/00 (EP); A61P27/02 (EP); A61P29/00 (EP);
A61P31/00 (EP); A61P35/00 (EP); A61P43/00 (EP);
A61P7/02 (EP); A61P9/00 (EP); A61P9/10 (EP);
C07D209/18 (EP,KR,US); C07D403/12 (EP,KR,US); C07D417/14 (EP,KR,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2002/45]
Extension statesALNot yet paid
LT12.06.2002
LV12.06.2002
MKNot yet paid
RO12.06.2002
SI12.06.2002
TitleGerman:INDOL-3-YL-DERIVATE UND DEREN VERWENDUNG ALS INTEGRIN-INHIBITOREN[2002/45]
English:INDOL-3-YL DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITORS[2004/46]
French:DERIVES DE 3-INDOLE ET LEUR UTILISATION COMME INHIBITEURS D'INTEGRINE[2004/46]
Former [2002/45]INDOL-3-YL DERIVATIVES
Former [2002/45]DERIVES D'INDOL-3-YL
Entry into regional phase12.06.2002National basic fee paid 
12.06.2002Designation fee(s) paid 
12.06.2002Examination fee paid 
Examination procedure12.08.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
12.06.2002Examination requested  [2002/45]
28.11.2002Despatch of a communication from the examining division (Time limit: M04)
05.03.2003Reply to a communication from the examining division
14.04.2003Despatch of a communication from the examining division (Time limit: M04)
21.07.2003Reply to a communication from the examining division
29.10.2004Communication of intention to grant the patent
26.01.2005Fee for grant paid
26.01.2005Fee for publishing/printing paid
Opposition(s)23.01.2006No opposition filed within time limit [2006/15]
Fees paidRenewal fee
14.01.2003Renewal fee patent year 03
14.01.2004Renewal fee patent year 04
12.01.2005Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY20.04.2005
TR20.04.2005
DK20.07.2005
GR20.07.2005
AT05.01.2006
FI05.01.2006
IE05.01.2006
SE06.01.2006
[2009/02]
Former [2008/37]TR20.04.2005
DK20.07.2005
GR20.07.2005
AT05.01.2006
FI05.01.2006
IE05.01.2006
SE06.01.2006
Former [2007/28]DK20.07.2005
GR20.07.2005
AT05.01.2006
FI05.01.2006
IE05.01.2006
SE06.01.2006
Former [2006/51]DK20.07.2005
GR20.07.2005
FI05.01.2006
IE05.01.2006
SE06.01.2006
Former [2006/48]DK20.07.2005
GR20.07.2005
IE05.01.2006
SE06.01.2006
Former [2006/14]DK20.07.2005
GR20.07.2005
Former [2006/13]DK20.07.2005
Cited inInternational search[DA]WO9412478  (SMITHKLINE BEECHAM CORP [US], et al) [DA] 1,7-11 * page 1 - page 2; example 9 *;
 [A]WO9737655  (MERCK & CO INC [US], et al) [A] 1,7-11 * claims 1,11,12 *;
 [A]WO9933798  (YAMANOUCHI PHARMA CO LTD [JP], et al) [A] 1,7-11* page 34 - page 35 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.